May 23, 2024  Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the "Notes") under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, resulting in ...